Intranasal fentanyl is a feasible, safe, and effective option for managing acute pain episodes in adults with sickle cell ...

Columnist Oluwatosin Adesoye, a doctor, sorts through the difference between sickle cell anemia and sickle cell disease — and ...

A month after a sickle cell pain crisis, columnist Dunstan Nicol-Wilson is learning how to trust his body again, which isn't easy.

The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke ...

The first healthy volunteer has been dosed in a Phase 1 study of Cellarity's novel globin-switching therapy CLY-124 for ...

As a result of being a caregiver for her cousin, columnist Sylvia Amuta says she's now more caring, compassionate, and kind ...

Most people with SCD seem to meet or exceed current level of physical activity recommendations for the general population, a study shows.

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 trial.

A program offering comprehensive primary and specialist care for adults with SCD reduced visits to the emergency department, a study found.

Variations in inflammation may contribute to vaso-occlusive events (VOEs) during the menstrual cycles of women with SCD, per a study.

With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.